166 related articles for article (PubMed ID: 1997637)
1. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
Berglund B; Ekblom B
J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
[TBL] [Abstract][Full Text] [Related]
2. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
[TBL] [Abstract][Full Text] [Related]
3. Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans.
Wilkerson DP; Rittweger J; Berger NJ; Naish PF; Jones AM
J Physiol; 2005 Oct; 568(Pt 2):639-52. PubMed ID: 16081477
[TBL] [Abstract][Full Text] [Related]
4. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
7. Response to erythropoietin in anaemic haemodialysis patients.
Nielsen OJ; Thaysen JH
J Intern Med; 1989 Aug; 226(2):89-94. PubMed ID: 2671248
[TBL] [Abstract][Full Text] [Related]
8. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
Randolph JF; Stokol T; Scarlett JM; MacLeod JN
Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
[TBL] [Abstract][Full Text] [Related]
9. Effect of rhEPO administration on serum levels of sTfR and cycling performance.
Birkeland KI; Stray-Gundersen J; Hemmersbach P; Hallen J; Haug E; Bahr R
Med Sci Sports Exerc; 2000 Jul; 32(7):1238-43. PubMed ID: 10912888
[TBL] [Abstract][Full Text] [Related]
10. [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses].
Soukup J; Menzel M; Roth S; Radke J
Anaesthesist; 1996 Aug; 45(8):745-9. PubMed ID: 8967587
[TBL] [Abstract][Full Text] [Related]
11. Blood boosting and sport.
Ekblom BT
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):89-98. PubMed ID: 10932813
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.
Oberhoff C; Neri B; Amadori D; Petry KU; Gamucci T; Rebmann U; Nowrousian MR; Voigtmann R; Monfardini S; Armand JP; Herrmann R; Netter-Pinon J; Tubiana-Mathieu N; Zwierzina H
Ann Oncol; 1998 Mar; 9(3):255-60. PubMed ID: 9602258
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
[TBL] [Abstract][Full Text] [Related]
15. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
Charuruks N; Voravud N; Limpanasithikul W
J Clin Lab Anal; 2001; 15(5):260-6. PubMed ID: 11574955
[TBL] [Abstract][Full Text] [Related]
16. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO).
Rau B; Schlag PM; Willeke F; Herfarth C; Stephan P; Franke W
Eur J Cancer; 1998 Jun; 34(7):992-8. PubMed ID: 9849445
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of prolonged strenuous endurance exercise on the level of haematocrit in amateur cyclists.
Neumayr G; Pfister R; Mitterbauer G; Gaenzer H; Joannidis M; Eibl G; Hoertnagl H
Int J Sports Med; 2002 Apr; 23(3):158-61. PubMed ID: 11914976
[TBL] [Abstract][Full Text] [Related]
18. Hematological adaptations and detection of recombinant human erythropoietin combined with chronic hypoxia.
Bejder J; Breenfeldt Andersen A; Bonne TC; Linkis J; Olsen NV; Huertas JR; Nordsborg NB
Drug Test Anal; 2021 Feb; 13(2):360-368. PubMed ID: 32955164
[TBL] [Abstract][Full Text] [Related]
19. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.
Lundin AP; Akerman MJ; Chesler RM; Delano BG; Goldberg N; Stein RA; Friedman EA
Nephron; 1991; 58(3):315-9. PubMed ID: 1910154
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin in the treatment of cancer-related anaemia.
Kasper C; Terhaar A; Fosså A; Welt A; Seeber S; Nowrousian MR
Eur J Haematol; 1997 Apr; 58(4):251-6. PubMed ID: 9186536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
